Atlas Trials

Genetic Diseases, X-Linked

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Genetic Diseases, X-Linked

RecordFirmDate
A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (NCT05126758)Capricor Inc.2022-06-22
A Trial of Metformin in Individuals With Fragile X Syndrome (Met) (NCT03862950)University of Alberta2019-05-24
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors (NCT03734588)Spark Therapeutics, Inc.2019-01-30
Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants (NCT03876301)Spark Therapeutics, Inc.2019-01-21
A Trial of Metformin in Individuals With Fragile X Syndrome (NCT03479476)University of California, Davis2018-04-30
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (NCT03406780)Capricor Inc.2018-04-04
Kidney Information Network for Disease Research and Education (NCT03321604)Massachusetts General Hospital2018-01-01
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy (NCT03179631)PTC Therapeutics2017-07-06
An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy (NCT02090959)PTC Therapeutics2014-03-20
Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) (NCT01826487)PTC Therapeutics2013-03-26
Genetic Studies of X-linked Lymphoproliferative Disease (NCT00359411)National Institute of Allergy and Infectious Diseases (NIAID)1996-05-22
Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping (NCT07250737)Avidity Biosciences, Inc.

Track Genetic Diseases, X-Linked automatically

Every clearance here is in the API, with alerts when new ones post.